and that price point will likely quadruple under Sanofi's name. Moral to the story, Don't sell. Keep these shares for a very long time. If you need any more advise, Buffet is in SNY too but he probably does not see Afrezza and the MNKD revolution coming. Smarter than Buffet, who does that?
Good theory. SNY is doing their own real world study right now. They will know long before the FDA in Jan. what is on the table here for extending the label. From a buyout perspective, buy out AL before the real world data is born out in 2016. If Afrezza is to become best selling drug greater than 140 billion per Lipitor give AL 30 billion for Afrezza as the drug will likely sell over 200 billion. AL needs to get paid so pay him $75.00 per share.
Slow launch, get the public educated, build a successful happy population using Afrezza. SNY has initiated a study Afrezza is going to be a better treatment that ends in Jan 2015. Once the label can say this, then the TV adds with big push next year igniting the mushroom cloud of demand. Then everyone will say boy I wished I would have bought this stock long in 2015.
MNKD longs are presently the smartest investors in the stock market...all one needs to know. Just put your shares away for a few years.
also Toujeo is going to get competition from the generic Lantus drugs that are going to be much much cheaper. I think this is why SNY pushed their drug. As the years go by, it is MNKD's afrezza that will be the exclusive money maker. Nothing can touch Afrezza, the world's first 200 billion dollar drug.
as advertisement with word-of-mouth set in. Scripts will go thru the roof and Wall Street goes from a hate to love relationship to the stock. Cramer will say get into MNKD, he got it wrong and should have saw it coming and will have Al Man on the show again. Present Longs will clean up. Beautiful.
equity will be out, junior debt will be out, senior debt will be the new owners. That's why no new debt buy backs and management treating shareholders like they are not relevant, because they are not.
no, a great forceful push down and recovery is needed. Hit piece came out before earnings and cc. If nothing happens on the releases (likely) then maybe it finally happens. We need the event that changes this mess, silence and no real info only leads stock lower.
Well I never thought the price would get this low when GS gave the downgrade but we are almost there. Unless there is a BO in the works, these clowns leading mnkd have nothing short term to offer. So down thru $3 we go. The short harvest is bountiful like a full orchard of apples if a surprise works out somewhere.
..also perhaps this could happen after with the wiping of the debt and the only investors making any money off this entity, the bondholders, finally get their haircut and remaining bag. No one is going to want to get into that debt.
..By that time SNY will have their market success story customers up and running. The education process should be completed, inventory bursting at the seams.........and then they go nuclear on TV.
He needs to be brought up on this issue when they have the CC. I am sure he will be. It is apparent he does not care about the future of this company. He can cancel these trades if he wants to. I wonder why he doesn't do that - because he really wants to sell.
GS was right, the shorts were right, where's the bottom? At some point it will be over, but we are headed into the 3's as predicted. No hope left.
Imagine the short panic if in the next 15 days SNY takes that 7 billion on reserve to buy MNKD at $15.00. The news comes out after the close and the shorts push the price up to 20.00 the next day! Not sure they can push the price to $1 without any news. But at this stage, a greedy short needs to get toasted for not taking profits. Not much left to get, maybe $3.00